In our own data, we also found that the ratio of CD163- to CD68-positive macrophages was higher in high histological and Ki67 index breast cancer, where the proportion was nearly 80% in the HR-negative subtype and only about 40% in the HR-positive subtype (data not shown). Here, CD163 is linked to breast carcinoma.